/Investor DB

BioVentures — 2010 Investments

1 investments dated 2010 · listed companies and verified rows first · show all

Hydrocisionhydrocision.comin𝕏Sep 2010

HydroCision develops minimally invasive surgical instruments using proprietary FluidJet technology to selectively remove soft tissue in a precise manner.

BiotechHardwareHealthtechMedical DevicesNorth Billerica, US

PAUL KOWALSKI(Executive Officer)inRICHARD A. LYTLE, III(Executive Officer, Director)THOMAS D. ABERT(Executive Officer)inPATRICIA VANBLARCOM(Executive Officer)Rick Lytle(President & Chief Executive Officer)in

BoardLONG ZHAN(Director)

Co-investorsNewbury VenturesOxford Bioscience Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.